BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7857331)

  • 1. Synthesis and preliminary pharmacological evaluation of pidotimod, its enantiomer, diastereomers and carboxamido derivatives.
    Magni A; Signorelli G; Bocchiola G
    Arzneimittelforschung; 1994 Dec; 44(12A):1402-4. PubMed ID: 7857331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental immunological screening tests on pidotimod.
    Coppi G; Manzardo S
    Arzneimittelforschung; 1994 Dec; 44(12A):1411-6. PubMed ID: 7857333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pidotimod on macrophage functions in methylprednisolone-treated mice.
    Taramelli D; Malabarba MG; Basilico N; Sala G; Mattina R; Cocuzza C
    Arzneimittelforschung; 1994 Dec; 44(12A):1425-30. PubMed ID: 7857336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical and chemical profile of pidotimod.
    Crimella T; Orlandi R; Bocchiola G; Anders U; Stradi R
    Arzneimittelforschung; 1994 Dec; 44(12A):1405-10. PubMed ID: 7857332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pidotimod on the immune and the neuroendocrine system in the aging rat.
    Chiarenza A; Iurato MP; Barbera N; Lempereur L; Cantarella G; Scapagnini U; Scapagnini G; Bernardini R
    Arzneimittelforschung; 1994 Dec; 44(12A):1437-40. PubMed ID: 7857338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulating activity of pidotimod.
    Migliorati G; Nicoletti I; Riccardi C
    Arzneimittelforschung; 1994 Dec; 44(12A):1421-4. PubMed ID: 7857335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pidotimod. A new biological response modifier. Introduction.
    Maillard F
    Arzneimittelforschung; 1994 Dec; 44(12A):1399-401. PubMed ID: 7857330
    [No Abstract]   [Full Text] [Related]  

  • 8. Protective effects of pidotimod against experimental bacterial infections in mice.
    Coppi G; Falcone A; Manzardo S
    Arzneimittelforschung; 1994 Dec; 44(12A):1417-21. PubMed ID: 7857334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of PGT/1A, a new immunostimulating drug, on macrophages and lymphocytes in immunodepressed mice.
    Barchielli M; Coppi G
    Acta Physiol Hung; 1990; 75 Suppl():25-6. PubMed ID: 2371881
    [No Abstract]   [Full Text] [Related]  

  • 10. General pharmacology of pidotimod and testing for drug interactions.
    Manzardo S; Falcone A; Pinzetta A; Ieva G; Coppi G
    Arzneimittelforschung; 1994 Dec; 44(12A):1441-7. PubMed ID: 7857339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression for interleukin-2 and tumor necrosis factor-alpha in the spleen of old rats under physiological condition and during septic shock. Possible pharmacological modulation.
    Annoni G; Arosio B; Santambrogio D; CullurĂ  D; Gagliano N; Uslenghi C
    Arzneimittelforschung; 1994 Dec; 44(12A):1433-6. PubMed ID: 7531977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo antiviral effects of pidotimod.
    Dianzani C; Colangelo D; Tonso E; Guidotto S; Viano I
    Arzneimittelforschung; 1994 Dec; 44(12A):1431-3. PubMed ID: 7857337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pidotimod in the management of recurrent pharyngotonsillar infections in childhood.
    Passali D; Calearo C; Conticello S
    Arzneimittelforschung; 1994 Dec; 44(12A):1511-6. PubMed ID: 7857354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pidotimod activity against chronic bronchitis exacerbations.
    Ciaccia A
    Arzneimittelforschung; 1994 Dec; 44(12A):1516-20. PubMed ID: 7857355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Potentiation of the resistance to viral and bacterial infections after pidotimod administration in mice].
    Marelli P; Lupetti A; Senesi S; Uslenghi C; Girardello R; Campa M
    Drugs Exp Clin Res; 1993; 19 Suppl():15-21. PubMed ID: 8625778
    [No Abstract]   [Full Text] [Related]  

  • 16. Ex vivo evaluation of pidotimod activity in patients with chronic obstructive pulmonary disease.
    Benetti GP; Illeni MT; Passera A; Bombelli G; Lavecchia G; Uslenghi C
    Arzneimittelforschung; 1994 Dec; 44(12A):1503-5. PubMed ID: 7857352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo evaluation of pidotimod activity on cell-mediated immunity.
    Benetti GP; Fugazza L; Stramba Badiale M; Montalto F; Bombelli G; La Vecchia G; Illeni MT; Uslenghi C
    Arzneimittelforschung; 1994 Dec; 44(12A):1476-9. PubMed ID: 7857346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of pidotimod in elderly volunteers and in renal failure patients.
    Spotti D; Biffi M; Coppi G; Silingardi S; Mailland F
    Arzneimittelforschung; 1994 Dec; 44(12A):1470-2. PubMed ID: 7857344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the efficacy of pidotimod in the exacerbations in patients affected with chronic bronchitis.
    Bisetti A; Ciappi G; Bariffi F; Catena E; Rocco V; Vaccaro L; Grassi V; Scarpazza G; Bertoli L; Cardani A
    Arzneimittelforschung; 1994 Dec; 44(12A):1499-502. PubMed ID: 7857351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the kinetics of the immunomodulating activity of Pidotimod on human neutrophils.
    Capsoni F; Minonzio F; Ongari AM; Girardello R; Zanussi C
    Pharmacol Res; 1992 Sep; 26 Suppl 2():172-3. PubMed ID: 1409296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.